Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome

Abstract Background Patients with metabolic syndrome (MetS) are at increased risk of asymptomatic hyperuricemia (i.e., elevated serum uric acid (SUA) level without gout) and cardiovascular disease. We conducted a cross-sectional study to examine associations between SUA levels and coronary flow rese...

Full description

Bibliographic Details
Main Authors: Seoyoung C. Kim, Marcelo F. Di Carli, Rajesh K. Garg, Kathleen Vanni, Penny Wang, Alyssa Wohlfahrt, Zhi Yu, Fengxin Lu, Anarosa Campos, Courtney F. Bibbo, Stacy Smith, Daniel H. Solomon
Format: Article
Language:English
Published: BMC 2018-06-01
Series:BMC Rheumatology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s41927-018-0027-6
id doaj-bac6e76264854c619d2e8b77583bf5dd
record_format Article
spelling doaj-bac6e76264854c619d2e8b77583bf5dd2020-11-25T01:51:14ZengBMCBMC Rheumatology2520-10262018-06-01211710.1186/s41927-018-0027-6Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndromeSeoyoung C. Kim0Marcelo F. Di Carli1Rajesh K. Garg2Kathleen Vanni3Penny Wang4Alyssa Wohlfahrt5Zhi Yu6Fengxin Lu7Anarosa Campos8Courtney F. Bibbo9Stacy Smith10Daniel H. Solomon11Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Nuclear Medicine, Department of Radiology, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Endocrinology, Diabetes & Hypertension, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Nuclear Medicine, Department of Radiology, Brigham and Women’s Hospital, Harvard Medical SchoolDepartment of Radiology, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolAbstract Background Patients with metabolic syndrome (MetS) are at increased risk of asymptomatic hyperuricemia (i.e., elevated serum uric acid (SUA) level without gout) and cardiovascular disease. We conducted a cross-sectional study to examine associations between SUA levels and coronary flow reserve and urate deposits in carotid arteries in patients with asymptomatic hyperuricemia and MetS. Methods Adults aged ≥40 years with MetS and SUA levels ≥6.5 mg/dl, but no gout, were eligible. Using a stress myocardial perfusion positron emission tomography (PET), we assessed myocardial blood flow (MBF) at rest and stress and calculated coronary flow reserve (CFR). CFR < 2.0 is considered abnormal and associated with increased cardiovascular risk. We also measured insulin resistance by homeostatic model assessment (HOMA-IR) method and urate deposits using dual-energy CT (DECT) of the neck for the carotid arteries. Results Forty-four patients with the median age of 63.5 years underwent a blood test, cardiac PET and neck DECT scans. Median (IQR) SUA was 7.8 (7.1–8.4) mg/dL. The median (IQR) CFR was abnormally low at 1.9 (1.7–2.4) and the median (IQR) stress MBF was 1.7 (1.3–2.2) ml/min/g. None had urate deposits in the carotid arteries detected by DECT. In multivariable linear regression analyses, SUA had no association with CFR (β = − 0.12, p = 0.78) or stress MBF (β = − 0.52, p = 0.28). Among non-diabetic patients (n = 25), SUA was not associated with HOMA-IR (β = 2.08, p = 0.10). Conclusions Among MetS patients with asymptomatic hyperuricemia, we found no relationship between SUA and CFR, stress MBF, and insulin resistance. No patients had any DECT detectable subclinical urate deposition in the carotid arteries.http://link.springer.com/article/10.1186/s41927-018-0027-6Uric acidMetabolic syndromePET/CTDECTCoronary blood flow
collection DOAJ
language English
format Article
sources DOAJ
author Seoyoung C. Kim
Marcelo F. Di Carli
Rajesh K. Garg
Kathleen Vanni
Penny Wang
Alyssa Wohlfahrt
Zhi Yu
Fengxin Lu
Anarosa Campos
Courtney F. Bibbo
Stacy Smith
Daniel H. Solomon
spellingShingle Seoyoung C. Kim
Marcelo F. Di Carli
Rajesh K. Garg
Kathleen Vanni
Penny Wang
Alyssa Wohlfahrt
Zhi Yu
Fengxin Lu
Anarosa Campos
Courtney F. Bibbo
Stacy Smith
Daniel H. Solomon
Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome
BMC Rheumatology
Uric acid
Metabolic syndrome
PET/CT
DECT
Coronary blood flow
author_facet Seoyoung C. Kim
Marcelo F. Di Carli
Rajesh K. Garg
Kathleen Vanni
Penny Wang
Alyssa Wohlfahrt
Zhi Yu
Fengxin Lu
Anarosa Campos
Courtney F. Bibbo
Stacy Smith
Daniel H. Solomon
author_sort Seoyoung C. Kim
title Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome
title_short Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome
title_full Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome
title_fullStr Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome
title_full_unstemmed Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome
title_sort asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome
publisher BMC
series BMC Rheumatology
issn 2520-1026
publishDate 2018-06-01
description Abstract Background Patients with metabolic syndrome (MetS) are at increased risk of asymptomatic hyperuricemia (i.e., elevated serum uric acid (SUA) level without gout) and cardiovascular disease. We conducted a cross-sectional study to examine associations between SUA levels and coronary flow reserve and urate deposits in carotid arteries in patients with asymptomatic hyperuricemia and MetS. Methods Adults aged ≥40 years with MetS and SUA levels ≥6.5 mg/dl, but no gout, were eligible. Using a stress myocardial perfusion positron emission tomography (PET), we assessed myocardial blood flow (MBF) at rest and stress and calculated coronary flow reserve (CFR). CFR < 2.0 is considered abnormal and associated with increased cardiovascular risk. We also measured insulin resistance by homeostatic model assessment (HOMA-IR) method and urate deposits using dual-energy CT (DECT) of the neck for the carotid arteries. Results Forty-four patients with the median age of 63.5 years underwent a blood test, cardiac PET and neck DECT scans. Median (IQR) SUA was 7.8 (7.1–8.4) mg/dL. The median (IQR) CFR was abnormally low at 1.9 (1.7–2.4) and the median (IQR) stress MBF was 1.7 (1.3–2.2) ml/min/g. None had urate deposits in the carotid arteries detected by DECT. In multivariable linear regression analyses, SUA had no association with CFR (β = − 0.12, p = 0.78) or stress MBF (β = − 0.52, p = 0.28). Among non-diabetic patients (n = 25), SUA was not associated with HOMA-IR (β = 2.08, p = 0.10). Conclusions Among MetS patients with asymptomatic hyperuricemia, we found no relationship between SUA and CFR, stress MBF, and insulin resistance. No patients had any DECT detectable subclinical urate deposition in the carotid arteries.
topic Uric acid
Metabolic syndrome
PET/CT
DECT
Coronary blood flow
url http://link.springer.com/article/10.1186/s41927-018-0027-6
work_keys_str_mv AT seoyoungckim asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome
AT marcelofdicarli asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome
AT rajeshkgarg asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome
AT kathleenvanni asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome
AT pennywang asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome
AT alyssawohlfahrt asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome
AT zhiyu asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome
AT fengxinlu asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome
AT anarosacampos asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome
AT courtneyfbibbo asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome
AT stacysmith asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome
AT danielhsolomon asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome
_version_ 1724997729032077312